Posted on October 15, 202010/15/20
Agreement outlines commercialization and distribution services to support patients diagnosed with Alagille syndrome FOSTER CITY, Calif. — Oct. 15, 2020– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced it has partnered with EVERSANA™, a leading provider of commercial services to […]
Posted on September 28, 20209/28/20
Agreement outlines commercialization and distribution services to enhance market access for patients diagnosed with fecal incontinence SANTA BARBARA, CALIF. AND STOCKHOLM – September 28, 2020 – Palette Life Sciences, a fully integrated life sciences company, today announced it has partnered with EVERSANA™, a leading provider of commercial services to the life science industry, to enhance […]
Posted on September 16, 20209/16/20
CHICAGO – September 16, 2020 – EVERSANA™, the leading provider of global commercial services to the life sciences industry, today launched ACTICS by EVERSANA™, the technology-enabled solution to optimize end-to-end commercial success for life science companies. Combining the power of AI-driven predictive analytics with ready-to-deploy, real-time commercial services, ACTICS provides the cloud-based solution pharmaceutical innovators […]
Posted on September 9, 20209/9/20
CHICAGO – September 9, 2020 – EVERSANA™, the leading provider of commercial services to the life science industry, today announced the acquisition of Alkemy Partners, a full-service field learning and development company committed to solving market access, sales and clinical engagement through training, content creation and digital solutions. The acquisition of the New Hampshire-based company […]
Posted on August 25, 20208/25/20
Gimoti commercial launch on track for the fourth quarter of 2020 SOLANA BEACH, Calif. and CHICAGO, Aug. 25, 2020 – Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases and EVERSANA™, a leading provider of global commercial services to the life science industry, today announced that EVERSANA has […]
Posted on August 6, 20208/6/20
Agreement outlines commercialization and distribution execution strategy upon FDA approval EVERSANA to provide commercial services of approximately $250 million over 5 years FREMONT, Calif., August 6, 2020 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced it has partnered with EVERSANA, a leading provider of commercial services to the life science […]
Posted on July 30, 20207/30/20
CHICAGO – July 30, 2020 – EVERSANA™, the leading provider of commercial services to the life science industry, and Havas Health & You (HH&Y), the world’s largest global health and wellness network, today announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and […]
Posted on July 29, 20207/29/20
Integrated Commercial Services and Personalized Therapy Management systems to seamlessly track product and patient journey SAN FRANCISCO, Calif. and CHICAGO, Illinois – July 29, 2020 – Vineti, the California-based company that offers a digital platform to enable broad access to advanced therapeutics, and EVERSANA™, a provider of global integrated commercial services to the life science […]
Posted on July 23, 20207/23/20
CHICAGO – July 23, 2020 – EVERSANA™, the leading provider of global commercial services to the life sciences industry, today announced a partnership with the Institute for Clinical and Economic Review (ICER) to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments. ICER is an independent nonprofit […]
Posted on May 4, 20205/4/20
Seasoned financial executive to shepherd global growth and scale of commercial service platform CHICAGO – May 4, 2020 – EVERSANA™, the leading independent provider of global commercial services to the life sciences industry, today announced the appointment of Kelly Baker to Chief Financial Officer (CFO). Baker will direct the company’s financial excellence and lead the […]
